Patient blood management in elective bypass cardiac surgery: A 2-step single-centre interventional trial to analyse the impact of an educational programme and erythropoiesis stimulation on red blood cell transfusion

Hélène Charbonneau, Marie Pasquié, Pierre Berthoumieu, Nicolas Savy, Gérard Autones, Olivier Anglès, Anne Laure Berthelot, Madeleine Croute-Bayle, Isabelle Decramer, David Duterque, Yannick Gabiache, Valérie Julien, Laurent Mallet, Mimoun M'rini, Jean François Quedreux, Benoit Richard, Laurent Sidobre, Laurence Taillefer, Philippe Soula, Olivier Garcia, Issam Abouliatim, Olivier Vahdat, Marc Bousquet, Jean Marc Ferradou, Yves Jansou, Pierre Brunel, Claude Breil, Nicolas Mayeur, Hélène Charbonneau, Marie Pasquié, Pierre Berthoumieu, Nicolas Savy, Gérard Autones, Olivier Anglès, Anne Laure Berthelot, Madeleine Croute-Bayle, Isabelle Decramer, David Duterque, Yannick Gabiache, Valérie Julien, Laurent Mallet, Mimoun M'rini, Jean François Quedreux, Benoit Richard, Laurent Sidobre, Laurence Taillefer, Philippe Soula, Olivier Garcia, Issam Abouliatim, Olivier Vahdat, Marc Bousquet, Jean Marc Ferradou, Yves Jansou, Pierre Brunel, Claude Breil, Nicolas Mayeur

Abstract

Anaemia and iron deficiency are frequent in patients scheduled for cardiac surgery. Perioperative patient blood management (PBM) is widely recommended in current practice guidelines. The aim of this protocol is to analyse the effect of a global perioperative PBM programme on the red blood cell (RBC) transfusion ratio, morbidities and rehabilitation score in elective cardiac surgery.This study is a prospective, single-centre trial with a 2-step protocol, A and B, as follows: A: non-drug intervention: the caregiver is given a blood management educational programme; B: drug intervention: systematic correction of perioperative iron, vitamin deficiencies, and anaemia. This study was designed to enrol 900 patients (500 in group A and 400 in group B) in a rolling period starting at anaesthesia consultation and ending 3 months after surgery. The primary objective was a 20% reduction in RBC transfusion after implementation of PBM programmes (protocol A + B) when compared to our previous transfusion ratio in the first half of 2018 (30.4% vs 38%). The secondary objectives were to evaluate the impact for each step of the study on the RBC transfusion rate, morbidity and the quality of postoperative rehabilitation.The strength of this study is its evaluation of the effect of a global PBM programme on RBC transfusion in cardiac surgery through a 2-step protocol. We aim to assess for the first time the impact of non-drug and drug interventions on RBC transfusion, comorbidities and delayed rehabilitation parameters.

Trials registrations: ClinicalTrials.gov, NCT04040023: registered 29 July 2019.

Keywords: Anaemia; Cardiac surgery; Erythropoietin; Iron deficiency; Red blood cell transfusion.

© 2020 Published by Elsevier Inc.

Figures

Fig. 1
Fig. 1
Summary diagram of the study.
Fig. 2
Fig. 2
Drug Intervention Programme (programme B). This diagram summarizes the preoperative drug intervention programme (programme B) in the second period of the study. Iron deficiency is defined by ferritin

References

    1. Karkouti K., Wijeysundera D.N., Beattie W.S. Reducing Bleeding in Cardiac Surgery (RBC) Investigators, Risk associated with preoperative anemia in cardiac surgery: a multicenter cohort study. Circulation. 2008;117:478–484. doi: 10.1161/CIRCULATIONAHA.107.718353.
    1. Ranucci M., Baryshnikova E., Castelvecchio S., Pelissero G. Surgical and Clinical Outcome Research (SCORE) Group, Major bleeding, transfusions, and anemia: the deadly triad of cardiac surgery. Ann. Thorac. Surg. 2013;96:478–485. doi: 10.1016/j.athoracsur.2013.03.015.
    1. Murphy G.J., Reeves B.C., Rogers C.A., Rizvi S.I.A., Culliford L., Angelini G.D. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation. 2007;116:2544–2552. doi: 10.1161/CIRCULATIONAHA.107.698977.
    1. Karkouti K., Wijeysundera D.N., Yau T.M., Beattie W.S., Abdelnaem E., McCluskey S.A., Ghannam M., Yeo E., Djaiani G., Karski J. The independent association of massive blood loss with mortality in cardiac surgery. Transfusion (Paris) 2004;44:1453–1462. doi: 10.1111/j.1537-2995.2004.04144.x.
    1. Koch C.G., Li L., Van Wagoner D.R., Duncan A.I., Gillinov A.M., Blackstone E.H. Red cell transfusion is associated with an increased risk for postoperative atrial fibrillation. Ann. Thorac. Surg. 2006;82:1747–1756. doi: 10.1016/j.athoracsur.2006.05.045.
    1. Koch C.G., Li L., Duncan A.I., Mihaljevic T., Cosgrove D.M., Loop F.D., Starr N.J., Blackstone E.H. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit. Care Med. 2006;34:1608–1616. doi: 10.1097/01.CCM.0000217920.48559.D8.
    1. Piednoir P., Allou N., Driss F., Longrois D., Philip I., Beaumont C., Montravers P., Lasocki S. Preoperative iron deficiency increases transfusion requirements and fatigue in cardiac surgery patients: a prospective observational study. Eur. J. Anaesthesiol. 2011;28:796–801. doi: 10.1097/EJA.0b013e32834ad97b.
    1. American Society of Anesthesiologists Task force on perioperative blood management, practice guidelines for perioperative blood management: an updated report by the American society of anesthesiologists task force on perioperative blood management*. Anesthesiology. 2015;122:241–275. doi: 10.1097/ALN.0000000000000463.
    1. Raphael J., Mazer C.D., Subramani S., Schroeder A., Abdalla M., Ferreira R., Roman P.E., Patel N., Welsby I., Greilich P.E., Harvey R., Ranucci M., Heller L.B., Boer C., Wilkey A., Hill S.E., Nuttall G.A., Palvadi R.R., Patel P.A., Wilkey B., Gaitan B., Hill S.S., Kwak J., Klick J., Bollen B.A., Shore-Lesserson L., Abernathy J., Schwann N., Lau W.T. Society of cardiovascular anesthesiologists clinical practice improvement advisory for management of perioperative bleeding and hemostasis in cardiac surgery patients. Anesth. Analg. 2019;129(5):1209–1221. doi: 10.1213/ANE.0000000000004355.
    1. Task Force on Patient Blood Management for Adult Cardiac Surgery of the European Association for Cardio-Thoracic Surgery (EACTS) and the European Association of Cardiothoracic Anaesthesiology (EACTA), Boer C., Meesters M.I., Milojevic M., Benedetto U., Bolliger D., von Heymann C., Jeppsson A., Koster A., Osnabrugge R.L., Ranucci M., Ravn H.B., Vonk A.B.A., Wahba A., Pagano D. 2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery. J. Cardiothorac. Vasc. Anesth. 2018;32:88–120. doi: 10.1053/j.jvca.2017.06.026.
    1. EuroQol Group EuroQol--a new facility for the measurement of health-related quality of life. Health Policy Amst. Neth. 1990;16:199–208. doi: 10.1016/0168-8510(90)90421-9.
    1. Guyatt G.H., Sullivan M.J., Thompson P.J., Fallen E.L., Pugsley S.O., Taylor D.W., Berman L.B. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can. Med. Assoc. J. 1985;132:919–923.
    1. The Criteria Committee of the New York Heart Association :Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels (ninth ed.), Little, Brown & Co., n.d.
    1. Committee for Proprietary Medicinal Products Points to consider on switching between superiority and non-inferiority. Br. J. Clin. Pharmacol. 2001;52:223–228. doi: 10.1046/j.0306-5251.2001.01397-3.x.
    1. Kozek-Langenecker S.A., Ahmed A.B., Afshari A., Albaladejo P., Aldecoa C., Barauskas G., De Robertis E., Faraoni D., Filipescu D.C., Fries D., Haas T., Jacob M., Lancé M.D., Pitarch J.V.L., Mallett S., Meier J., Molnar Z.L., Rahe-Meyer N., Samama C.M., Stensballe J., Van der Linden P.J.F., Wikkelsø A.J., Wouters P., Wyffels P., Zacharowski K. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: first update 2016. Eur. J. Anaesthesiol. 2017;34:332–395. doi: 10.1097/EJA.0000000000000630.
    1. Society of Thoracic Surgeons Blood Conservation Guideline Task Force, Ferraris V.A., Brown J.R., Despotis G.J., Hammon J.W., Reece T.B., Saha S.P., Song H.K., Clough E.R., Society of Cardiovascular Anesthesiologists Special Task Force on Blood Transfusion, Shore-Lesserson L.J., Goodnough L.T., Mazer C.D., Shander A., Stafford-Smith M., Waters J., International Consortium for Evidence Based Perfusion, Baker R.A., Dickinson T.A., FitzGerald D.J., Likosky D.S., Shann K.G. Update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann. Thorac. Surg. 2011;91:944–982. doi: 10.1016/j.athoracsur.2010.11.078. 2011.
    1. Mueller M.M., Van Remoortel H., Meybohm P., Aranko K., Aubron C., Burger R., Carson J.L., Cichutek K., De Buck E., Devine D., Fergusson D., Folléa G., French C., Frey K.P., Gammon R., Levy J.H., Murphy M.F., Ozier Y., Pavenski K., So-Osman C., Tiberghien P., Volmink J., Waters J.H., Wood E.M., Seifried E. ICC PBM frankfurt 2018 group, patient blood management: recommendations from the 2018 frankfurt consensus conference. J. Am. Med. Assoc. 2019;321:983–997. doi: 10.1001/jama.2019.0554.
    1. D'Agostino R.S., Jacobs J.P., Badhwar V., Fernandez F.G., Paone G., Wormuth D.W., Shahian D.M. The society of thoracic surgeons adult cardiac surgery database: 2018 update on outcomes and quality. Ann. Thorac. Surg. 2018;105:15–23. doi: 10.1016/j.athoracsur.2017.10.035.
    1. D'Agostino R.S., Jacobs J.P., Badhwar V., Paone G., Rankin J.S., Han J.M., McDonald D., Edwards F.H., Shahian D.M. The society of thoracic surgeons adult cardiac surgery database: 2017 update on outcomes and quality. Ann. Thorac. Surg. 2017;103:18–24. doi: 10.1016/j.athoracsur.2016.11.001.
    1. Murphy G.J., Pike K., Rogers C.A., Wordsworth S., Stokes E.A., Angelini G.D., Reeves B.C. TITRe2 Investigators, Liberal or restrictive transfusion after cardiac surgery. N. Engl. J. Med. 2015;372:997–1008. doi: 10.1056/NEJMoa1403612.
    1. Mazer C.D., Whitlock R.P., Fergusson D.A., Hall J., Belley-Cote E., Connolly K., Khanykin B., Gregory A.J., de Médicis É., McGuinness S., Royse A., Carrier F.M., Young P.J., Villar J.C., Grocott H.P., Seeberger M.D., Fremes S., Lellouche F., Syed S., Byrne K., Bagshaw S.M., Hwang N.C., Mehta C., Painter T.W., Royse C., Verma S., Hare G.M.T., Cohen A., Thorpe K.E., Jüni P., Shehata N. TRICS investigators and perioperative anesthesia clinical trials group, restrictive or liberal red-cell transfusion for cardiac surgery. N. Engl. J. Med. 2017;377:2133–2144. doi: 10.1056/NEJMoa1711818.
    1. Bennett-Guerrero E., Zhao Y., O'Brien S.M., Ferguson T.B., Jr., Peterson E.D., Gammie J.S., Song H.K. Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA, J. Am. Med. Assoc. 2010;304:1568–1575. doi: 10.1001/jama.2010.1406.
    1. Spahn D.R., Schoenrath F., Spahn G.H., Seifert B., Stein P., Theusinger O.M., Kaserer A., Hegemann I., Hofmann A., Maisano F., Falk V. Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a prospective randomised trial. Lancet Lond. Engl. 2019;393:2201–2212. doi: 10.1016/S0140-6736(18)32555-8.
    1. Rössler J., Schoenrath F., Seifert B., Kaserer A., Spahn G.H., Falk V., Spahn D.R. Iron deficiency is associated with higher mortality in patients undergoing cardiac surgery: a prospective study. Br. J. Anaesth. 2019;124(1):25–34. doi: 10.1016/j.bja.2019.09.016.
    1. Chau M., Richards T., Evans C., Butcher A., Collier T., Klein A. The UK Cardiac and Vascular Surgery Interventional Anaemia Response (CAVIAR) Study: protocol for an observational cohort study to determine the impact and effect of preoperative anaemia management in cardiac and vascular surgical patients. BMJ Open. 2017;7 doi: 10.1136/bmjopen-2016-014872.
    1. Kei T., Mistry N., Curley G., Pavenski K., Shehata N., Tanzini R.M., Gauthier M.-F., Thorpe K., Schweizer T.A., Ward S., Mazer C.D., Hare G.M.T. Efficacy and safety of erythropoietin and iron therapy to reduce red blood cell transfusion in surgical patients: a systematic review and meta-analysis. Can. J. Anaesth. J. Can. Anesth. 2019;66:716–731. doi: 10.1007/s12630-019-01351-6.
    1. MANAGEMENT AND PREVENTION OF ANEMIA (EXCLUDING ACUTE HEMORRAGE) IN INTENSIVE CARE UNIT ADULT PATIENTS, (2019).
    1. Anker S.D., Comin Colet J., Filippatos G., Willenheimer R., Dickstein K., Drexler H., Lüscher T.F., Bart B., Banasiak W., Niegowska J., Kirwan B.-A., Mori C., von Eisenhart Rothe B., Pocock S.J., Poole-Wilson P.A., Ponikowski P. FAIR-HF Trial Investigators, Ferric carboxymaltose in patients with heart failure and iron deficiency. N. Engl. J. Med. 2009;361:2436–2448. doi: 10.1056/NEJMoa0908355.
    1. Ponikowski P., van Veldhuisen D.J., Comin-Colet J., Ertl G., Komajda M., Mareev V., McDonagh T., Parkhomenko A., Tavazzi L., Levesque V., Mori C., Roubert B., Filippatos G., Ruschitzka F., Anker S.D. CONFIRM-HF Investigators, Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†. Eur. Heart J. 2015;36:657–668. doi: 10.1093/eurheartj/ehu385.
    1. Tramarin R., Pistuddi V., Maresca L., Pavesi M., Castelvecchio S., Menicanti L., de Vincentiis C., Ranucci M. Surgical and Clinical Outcome Research (SCORE) Group, Patterns and determinants of functional and absolute iron deficiency in patients undergoing cardiac rehabilitation following heart surgery. Eur. J. Prev. Cardiol. 2017;24:799–807. doi: 10.1177/2047487317689975.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj